2-(4-Chlorophenyl)-1-(diisopropylphosphinyl)aziridine
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | 5jnUR3Ztz5d |
|---|---|
| InChI | InChI=1S/C14H21ClNO3P/c1-10(2)18-20(17,19-11(3)4)16-9-14(16)12-5-7-13(15)8-6-12/h5-8,10-11,14H,9H2,1-4H3/t14-,16?/m1/s1 |
| InChIKey | XEYULGSRJZCHDI-UHFFFAOYSA-N |
| Mol Weight | 317.75 g/mol |
| Molecular Formula | C14H21ClNO3P |
| Exact Mass | 317.094758 g/mol |
| Enantiomer InChIKey | XEYULGSRJZCHDI-LBAUFKAWSA-N |
| Copyright | Copyright © 2020-2025 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | JA-50-523-0 |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- 2-(4'-Chlorophenyl0-1-(diisopropylphosphinyl)aziridine
(E)-N-(1-(4-Chlorophenyl)-3-methyl-5-phenylpent-3-enyl)-4-methoxybenzenamine
1,2-Azaphosphorine, 2-ethoxyhexahydro-1-(phenylmethyl)-, 2-oxide
1H-tetrazole-1-propanoic acid, beta-(4-chlorophenyl)-
N1,N2-DIMETHYL-N1-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXAPHOSPHOLAN-2-YL)BENZAMIDINE
3,3-Dichloro-1-isopropyl-2-(4-methoxyphenyl)-azetidine
6-(N-BENZYLPIPERIDIN-4-YL-2-ETHYLAMIDO)-N-BENZYLOXYCARBONYL-S-ALPHA-AMINO-ADIPIC-ACID-1-ETHYLESTER
4-[1-(Diallylamino)-3-phenyl-2-propenyl]benzoic acid ethyl ester
1-[1-(4-Chlorophenyl)-2-phenyl-ethyl]imidazole
N-4-Methoxyphenyl-N-methyl-1-(1-phenylpropyl)piperidin-4-amine
anti,anti-2-[.alpha.-N,N-dimethylamino(4-chlorobenzyl)]aniline
| Title | Journal or Book | Year |
|---|---|---|
| Potential GABA B Receptor Antagonists. IX The Synthesis of 3-Amino-3-(4-chlorophenyl)propanoic Acid, 2-Amino-2-(4-chlorophenyl)ethylphosphonic Acid and 2-Amino-2-(4-chlorophenyl)ethanesulfonic Acid | Australian Journal of Chemistry | 1997 |
This compound is available in the following databases:
Wiley Registry of Mass Spectral Data 2023
Author: Wiley
The foundation library for any analytical laboratory running mass spectrometry, the Wiley Registry provides the broadest coverage available in any mass spectral library Learn more.